Search


Current filters:
Start a new search
Add filters:

Use filters to refine the search results.


Results 1-10 of 76
Item hits:
Issue DateTitleAuthor(s)
23-Oct-2017Thirty years of OncogeneMiller, G; Stebbing, J
31-Aug-2018Shedding of bevacizumab in tumour cells-derived extracellular vesicles as a new therapeutic escape mechanism in glioblastomaSimon, T; Pinioti, S; Schellenberger, P; Rajeeve, V; Wendler, F, et al
20-Dec-2009Unique Localization of Circulating Tumor Cells in Patients With Hepatic MetastasesJiao, LR; Apostolopoulos, C; Jacob, J; Szydlo, R; Johnson, N, et al
12-Dec-2017Brief report: geographic variation in EGFR mutation frequency in lung adenocarcinoma may be explained by interethnic genetic variationSoraas, L; Stebbing, J; National Institute for Health Research; Action Against Cancer
10-Apr-2013miR-23b regulates cytoskeletal remodeling, motility and metastasis by directly targeting multiple transcriptsPellegrino, L; Stebbing, J; Braga, VM; Frampton, AE; Jacob, J, et al
1-Sep-2016The ALBI grade provides objective hepatic reserve phenotyping across each BCLC stage of hepatocellular carcinoma.Pinato, DJ; Sharma, R; Yen, C; Arizumi, T; Kubota, K, et al
2-Mar-2018Nivolumab-induced fulminant diabetic ketoacidosis followed by thyroiditisTzoulis, P; Corbett, RW; Ponnampalam, S; Baker, E; Heaton, D, et al
1-Nov-2015HOT mutation screening in human glioblastomasKrell, D; Mulholland, P; Stebbing, J; Tomlinson, I; Bardella, C, et al
22-Jun-2017MSLN gene silencing has an anti-malignant effect on cell lines overexpressing mesothelin deriving from malignant pleural mesothelioma (vol 9, e85935, 2014)Melaiu, O; Stebbing, J; Lombardo, Y; Bracci, E; Uehara, N, et al
12-Jan-2018A randomised trial comparing the pharmacokinetics and safety of the biosimilar CT-P6 with reference trastuzumabEsteva, FJ; Stebbing, J; Wood-Horrall, RN; Winkle, PJ; Lee, SY, et al